Weekly signal · CRWV · Technology

CoreWeave (CRWV) volume rises above its 13-week norm as shares climb

The software-infrastructure stock remains in an active trend, with Market Dynamics confirmation offset by weak Relative Strength.

CoreWeave, Inc. Class A Common Stock
Latest117.95 USD
1W move17.3%
Volume1.1x
TrendActive
Data-center infrastructure screens and market charts representing CoreWeave’s AI-cloud business.

Market update

What happened

CoreWeave, Inc. Class A Common Stock (CRWV) closed at $117.95 for the week ended June 19, gaining 17.3% over one week and 11.8% over four weeks.

The weekly price path over 52 weeks shows a broader advance still in place, with the stock up 57.7% over twelve weeks. Trading volume reached 157.0 million shares, about 1.08 times the 13-week average.

The confirmation is not one-sided: Market Dynamics stood at 0.77, while Relative Strength remained negative at -6.3.

Continue your research

Explore CRWV across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.

CRWV coverage

Evidence context